Vaxcyte, Inc. (PCVX) — Business segments and KPIs
Revenue by business segment and geography for Vaxcyte, Inc., with year-over-year trends.
FY 2021
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Pneumococcal Conjugate Vaccine | 7.00B | 100.0% |
Revenue by business segment and geography for Vaxcyte, Inc., with year-over-year trends.
FY 2021
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Pneumococcal Conjugate Vaccine | 7.00B | 100.0% |